Developer docs
API playgroundTry for free, no card

Search company profiles

Lumexa Imaging

Full company profile

uuid000cxge

Namestring
Lumexa Imaging
Legal namestring
Lumexa Imaging, Inc.
Company typeenum
Public
Founded yearint
2018
Descriptiontext

Lumexa Imaging (NASDAQ: LMRI), founded in 2018 and formerly known as US Radiology Specialists, is the second-largest outpatient diagnostic imaging operator in the United States. The company runs 190+ freestanding imaging centers across 13 states, delivering MRI, CT, PET/CT, mammography, and interventional radiology services at approximately 60% lower cost than hospital outpatient departments. Approximately 4 million outpatient procedures were performed system-wide in 2025.

The company's technology platform comprises three proprietary or integrated layers: (1) Connexia, a wholly-owned teleradiology platform providing subspecialized remote interpretation across body imaging, breast, neuroradiology, musculoskeletal, pediatric, and emergency radiology, staffed by 1,000+ radiologists; (2) Scanslated, an AI-driven NLP tool that translates complex radiology reports into patient-friendly language (2M+ reports accessed); (3) a growing suite of AI integrations including Rad AI dictation (PACS-integrated generative AI) and an in-house computer vision pilot for breast arterial calcification detection on mammograms. PET imaging volumes grew 17.0% consolidated in 2025, supported by expanded radiopharmaceutical capabilities for prostate cancer and dementia imaging.

Lumexa generates revenue on a per-procedure basis reimbursed through Medicare, Medicaid, and commercial payors, supplemented by joint-venture economics with health-system partners. The growth model combines de novo center development (8–10 per year), tuck-in acquisitions, and joint ventures with leading health systems — currently nine JVs including Hospital for Special Surgery, UPMC, and Advocate Health, representing 85+ of the company's centers. FY2025 consolidated revenue was $1.023 billion (+7.8% YoY) with Adjusted EBITDA of $230.2 million (+14.6%), and FY2026 guidance is $1.045–$1.097 billion in revenue. The company is backed by Welsh, Carson, Anderson & Stowe and went public in December 2025 at a $1.75 billion valuation, using IPO proceeds to reduce leverage from 5.5x to 3.5x.

Short descriptiontext

Lumexa Imaging (NASDAQ: LMRI) is the second-largest U.S. outpatient diagnostic imaging operator, running 190+ freestanding centers across 13 states with 1,000+ subspecialized radiologists and the proprietary Connexia teleradiology platform, serving patients via direct referrals and through nine health-system joint ventures including HSS, UPMC, and Advocate Health.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersRaleigh, United States
HQ citystring
Raleigh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
outpatient diagnostic imaging, medical imaging services, teleradiology platform, mammography screening services, radiology practice partnerships
Industry2 codes
PRIMARYHLAFAKAA
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
SECONDARYHLACALAK
Teleradiology Platforms & Reading Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code1 code
  • Diagnostic Imaging Centers621512
SIC code1 code
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Outpatient Diagnostic Imaging Services
Social media profiles2 records
Revenue model3 records
1Outpatient Imaging Services
TypeTransaction Fee
Description

Lumexa Imaging generates the majority of its revenue through outpatient diagnostic imaging procedures conducted at its network of 190+ freestanding outpatient imaging centers across 13 U.S. states. Services include MRI, CT, PET/CT, mammography, and other advanced imaging modalities. Revenue is driven by procedure volumes, same-center growth, and new center additions. The company reported consolidated revenues of $252.5 million in Q1 2026 and $1.023 billion for full-year 2025.

lumexaimaging.com
2Joint Venture Partnerships with Health Systems
TypeManaged Services
Description

Revenue is also generated through joint venture partnerships with leading health systems including Advocate Health, UPMC, and Hospital for Special Surgery. These partnerships account for 85+ of 190+ imaging centers and provide a capital-efficient growth model, with 9 joint venture partnerships total as of June 2026.

lumexaimaging.com
3Teleradiology Services (Connexia)
TypeSubscription Recurring
Description

The Connexia teleradiology platform provides remote radiology interpretation services to Lumexa's own imaging centers as well as external clients, offering subspecialized radiology coverage across body imaging, breast imaging, neuroradiology, musculoskeletal radiology, pediatric radiology, and emergency radiology.

lumexaimaging.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Standard outpatient imaging procedure pricing (insurance-reimbursed)
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Imaging procedures are billed to health insurance plans, Medicare, and Medicaid. Reimbursement rates vary by modality, payor, and geography. Services are approximately 60% less expensive than hospital-based alternatives.

lumexaimaging.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Connexia
Description

Teleradiology platform providing remote radiology interpretation services with over 1,000 radiologists utilizing AI technology for accurate and timely diagnoses.

lumexaimaging.com
+2 more records
Core offering1 text field

Lumexa Imaging operates a national network of 190+ freestanding outpatient diagnostic imaging centers across 13 U.S. states, providing MRI, CT, PET/CT, mammography, and interventional radiology services to patients referred by physicians. The company complements its imaging centers with the proprietary Connexia teleradiology platform, delivering subspecialized remote radiology interpretations across body, breast, musculoskeletal, neuroradiology, pediatric, and emergency radiology supported by 1,000+ radiologists. AI-powered tools including Scanslated, Rad AI, FastScan, and breast arterial calcification detection enhance clinical quality, patient engagement, and operational efficiency across the network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Approximately 60% cost savings compared to hospital outpatient departments for equivalent imaging services (based on 2019 UnitedHealth Group claims analysis)
+6 more records
Product overview1 text field

Lumexa Imaging operates as a nationwide outpatient medical imaging provider with a platform combining over 190 outpatient imaging centers across 13 states, the Connexia teleradiology service for remote radiology interpretation, and AI-powered technology integrations. The core offering centers on diagnostic imaging services (MRI, CT, PET/CT, mammography, interventional) delivered at freestanding outpatient facilities. Connexia provides subspecialized teleradiology coverage, while AI tools including Scanslated for patient communication, Rad AI for dictation, and breast arterial calcification detection enhance clinical operations. The company also operates a Joint Ventures program partnering with health systems for strategic expansion.

Product and service2 records
1Outpatient Imaging Centers (MRI, CT, PET/CT, Mammography, Interventional Radiology)
CategoryOutpatient Diagnostic Imaging
Description

Network of 190+ freestanding outpatient medical imaging centers across 13 U.S. states delivering MRI, CT, PET/CT, mammography, and interventional radiology services to patients referred by physicians. Approximately 4 million outpatient procedures were conducted system-wide in 2025. Services are priced approximately 60% below hospital outpatient department equivalents and are billed to health insurance plans, Medicare, and Medicaid.

2Connexia Teleradiology
CategoryTeleradiology Services
Description

Proprietary teleradiology platform providing subspecialized remote radiology interpretation services across body imaging, breast imaging, musculoskeletal, neuroradiology, pediatric radiology, and emergency radiology. Supports Lumexa's 190+ imaging centers and external clients with a network of 1,000+ subspecialized radiologists, delivering accelerated turnaround times and reliable capacity amid national radiologist shortages.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-02
Description

Lumexa Imaging formed a strategic joint venture with Hospital for Special Surgery (HSS), world leader in musculoskeletal health ranked No. 1 in orthopedics by U.S. News & World Report for 16 consecutive years. The collaboration represents Lumexa's 9th joint venture and aims to expand access to advanced outpatient imaging services across the New York City metro area. The joint venture leverages HSS's subspecialized radiology expertise and supports Lumexa's growth in one of the nation's largest healthcare markets.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-13
Description

New joint venture partnership with UPMC (University of Pittsburgh Medical Center). Wexford, Pennsylvania site represents the first contribution from the new joint venture. North Pittsburgh Imaging Specialists in Pine Township was acquired and rebranded as UPMC | Touchstone Medical Imaging as part of this partnership. UPMC is a leading health system operating in Pennsylvania and surrounding states.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-13
Description

Joint venture partnership with Advocate Health, one of the largest health systems operating in seven states. A center in Concord, North Carolina was acquired as part of this joint venture partnership. Advocate Health represents an existing JV partner relationship supporting Lumexa's multi-channel growth strategy.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-11
Description

Lumexa Imaging partners with leading subspecialized private practice radiology groups across its 190+ center footprint. Each practice maintains local Clinical Governance Board (CGB) for patient care decisions and local hiring, scheduling, and salary decisions. Partners include Charlotte Radiology, Carolinas Imaging, Gateway Radiology, Rad Ltd, SJRA, Windsong Radiology, and others. Together the network comprises over 1,000 radiologists.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

RadNet is the largest U.S. outpatient diagnostic imaging network with ~400 centers across multiple states. It is the most direct competitor to Lumexa in freestanding MRI/CT/PET/mammography services and the #1 player in the same outpatient imaging category where Lumexa is #2.

TypeDirect peer
Description

SimonMed is one of the largest privately held outpatient diagnostic imaging providers in the U.S., offering MRI, CT, PET/CT, mammography, and other modalities. It competes head-to-head with Lumexa in many of the same MSAs and serves a similar patient and referring-physician base.

TypeDirect peer
Description

RAYUS Radiology (formerly Center for Diagnostic Imaging) is a national outpatient imaging network operating freestanding centers with MRI, CT, and other modalities. It is a directly comparable outpatient imaging peer to Lumexa, sharing the same freestanding-center, multi-modality service model.

TypeDirect peer
Description

Akumin operates a national network of freestanding outpatient imaging centers offering MRI, CT, PET/CT, and other diagnostic services. Despite recent financial restructuring, it remains a directly comparable outpatient diagnostic imaging peer to Lumexa.

TypeDirect peer
Description

Radiology Partners is the largest radiology practice in the U.S., serving hospitals and outpatient imaging centers through teleradiology and on-site radiologist staffing. It is directly comparable to Lumexa's Connexia teleradiology and subspecialized radiologist network, though it does not own imaging centers at scale.

TypeBroad incumbent
Description

Envision provides outsourced clinical staffing, including radiology, to hospitals and health systems across the U.S. It is a broader healthcare-services incumbent that overlaps with Lumexa's outsourced radiology and teleradiology services but across a much wider clinical portfolio.

TypeEmerging player
Description

SCA Health operates a national network of ambulatory surgery centers and partnered with Optum. While focused on outpatient surgery rather than imaging, SCA uses a similar health-system JV and capital-efficient expansion model that informed Lumexa's CGO Kyle Lynch (formerly SVP at SCA Health).

TypeBroad incumbent
Description

HCA is the largest U.S. for-profit hospital system and operates a broad network of hospital outpatient imaging departments. It is a broad incumbent whose HOPD imaging services compete with Lumexa's freestanding centers and whose joint-venture-friendly operating model is structurally relevant to Lumexa's JV strategy.

TypeBroad incumbent
Description

Tenet, through USPI, is the largest operator of ambulatory surgery centers and a major outpatient healthcare services platform. It is a broad incumbent with a similar JV-driven growth playbook, providing a comparable public-market benchmark for Lumexa's growth and margin trajectory.

TypeOthers
Description

Independent imaging AI and analytics vendors serve the same radiology customer base as Lumexa's Connexia teleradiology and AI tools. They are adjacent ecosystem participants whose competitive positioning directly affects Lumexa's technology differentiation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles21 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lumexa Imaging

Outpatient Diagnostic Imaging Serviceslumexaimaging.com

Lumexa Imaging (NASDAQ: LMRI) is the second-largest U.S. outpatient diagnostic imaging operator, running 190+ freestanding centers across 13 states with 1,000+ subspecialized radiologists and the proprietary Connexia teleradiology platform, serving patients via direct referrals and through nine health-system joint ventures including HSS, UPMC, and Advocate Health.

What Lumexa Imaging does

Lumexa Imaging (NASDAQ: LMRI), founded in 2018 and formerly known as US Radiology Specialists, is the second-largest outpatient diagnostic imaging operator in the United States. The company runs 190+ freestanding imaging centers across 13 states, delivering MRI, CT, PET/CT, mammography, and interventional radiology services at approximately 60% lower cost than hospital outpatient departments. Approximately 4 million outpatient procedures were performed system-wide in 2025.

The company's technology platform comprises three proprietary or integrated layers: (1) Connexia, a wholly-owned teleradiology platform providing subspecialized remote interpretation across body imaging, breast, neuroradiology, musculoskeletal, pediatric, and emergency radiology, staffed by 1,000+ radiologists; (2) Scanslated, an AI-driven NLP tool that translates complex radiology reports into patient-friendly language (2M+ reports accessed); (3) a growing suite of AI integrations including Rad AI dictation (PACS-integrated generative AI) and an in-house computer vision pilot for breast arterial calcification detection on mammograms. PET imaging volumes grew 17.0% consolidated in 2025, supported by expanded radiopharmaceutical capabilities for prostate cancer and dementia imaging.

Lumexa generates revenue on a per-procedure basis reimbursed through Medicare, Medicaid, and commercial payors, supplemented by joint-venture economics with health-system partners. The growth model combines de novo center development (8–10 per year), tuck-in acquisitions, and joint ventures with leading health systems — currently nine JVs including Hospital for Special Surgery, UPMC, and Advocate Health, representing 85+ of the company's centers. FY2025 consolidated revenue was $1.023 billion (+7.8% YoY) with Adjusted EBITDA of $230.2 million (+14.6%), and FY2026 guidance is $1.045–$1.097 billion in revenue. The company is backed by Welsh, Carson, Anderson & Stowe and went public in December 2025 at a $1.75 billion valuation, using IPO proceeds to reduce leverage from 5.5x to 3.5x.

Lumexa Imaging firmographics

Firmographics
Name
Lumexa Imaging
Legal name
Lumexa Imaging, Inc.
Website
https://lumexaimaging.com
Company type
Public
Founded year
2018
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Lumexa Imaging (NASDAQ: LMRI) is the second-largest U.S. outpatient diagnostic imaging operator, running 190+ freestanding centers across 13 states with 1,000+ subspecialized radiologists and the proprietary Connexia teleradiology platform, serving patients via direct referrals and through nine health-system joint ventures including HSS, UPMC, and Advocate Health.
Ownership category
akta.pro rank

Lumexa Imaging industry classification

Industry
Product category
Outpatient Diagnostic Imaging Services
NAICS
Diagnostic Imaging Centers (621512)
SIC
Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLAFAKAA
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
SECONDARYHLACALAK
Teleradiology Platforms & Reading Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Outpatient diagnostic imaging
  • Medical imaging services
  • Teleradiology platform
  • Mammography screening services
  • Radiology practice partnerships

Where Lumexa Imaging is headquartered

Location

Headquarters

HQ city
Raleigh
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Lumexa Imaging business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Outpatient Imaging Services: Lumexa Imaging generates the majority of its revenue through outpatient diagnostic imaging procedures conducted at its network of 190+ freestanding outpatient imaging centers across 13 U.S. states. Services include MRI, CT, PET/CT, mammography, and other advanced imaging modalities. Revenue is driven by procedure volumes, same-center growth, and new center additions. The company reported consolidated revenues of $252.5 million in Q1 2026 and $1.023 billion for full-year 2025.
  2. Joint Venture Partnerships with Health Systems: Revenue is also generated through joint venture partnerships with leading health systems including Advocate Health, UPMC, and Hospital for Special Surgery. These partnerships account for 85+ of 190+ imaging centers and provide a capital-efficient growth model, with 9 joint venture partnerships total as of June 2026.
  3. Teleradiology Services (Connexia): The Connexia teleradiology platform provides remote radiology interpretation services to Lumexa's own imaging centers as well as external clients, offering subspecialized radiology coverage across body imaging, breast imaging, neuroradiology, musculoskeletal radiology, pediatric radiology, and emergency radiology.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goStandard outpatient imaging procedure pricing (insurance-reimbursed)

Distribution channels3 records

Marketing channels5 records

Lumexa Imaging product offering

Product offering

Core offering

Lumexa Imaging operates a national network of 190+ freestanding outpatient diagnostic imaging centers across 13 U.S. states, providing MRI, CT, PET/CT, mammography, and interventional radiology services to patients referred by physicians. The company complements its imaging centers with the proprietary Connexia teleradiology platform, delivering subspecialized remote radiology interpretations across body, breast, musculoskeletal, neuroradiology, pediatric, and emergency radiology supported by 1,000+ radiologists. AI-powered tools including Scanslated, Rad AI, FastScan, and breast arterial calcification detection enhance clinical quality, patient engagement, and operational efficiency across the network.

Product overview

Lumexa Imaging operates as a nationwide outpatient medical imaging provider with a platform combining over 190 outpatient imaging centers across 13 states, the Connexia teleradiology service for remote radiology interpretation, and AI-powered technology integrations. The core offering centers on diagnostic imaging services (MRI, CT, PET/CT, mammography, interventional) delivered at freestanding outpatient facilities. Connexia provides subspecialized teleradiology coverage, while AI tools including Scanslated for patient communication, Rad AI for dictation, and breast arterial calcification detection enhance clinical operations. The company also operates a Joint Ventures program partnering with health systems for strategic expansion.

Differentiator

Problem solved

Functional benefit

Brands

  • Connexia: Teleradiology platform providing remote radiology interpretation services with over 1,000 radiologists utilizing AI technology for accurate and timely diagnoses.
  • Scanslated
  • FastScan

Products and services

  • Outpatient Imaging Centers (MRI, CT, PET/CT, Mammography, Interventional Radiology) Network of 190+ freestanding outpatient medical imaging centers across 13 U.S. states delivering MRI, CT, PET/CT, mammography, and interventional radiology services to patients referred by physicians. Approximately 4 million outpatient procedures were conducted system-wide in 2025. Services are priced approximately 60% below hospital outpatient department equivalents and are billed to health insurance plans, Medicare, and Medicaid.
  • Connexia Teleradiology Proprietary teleradiology platform providing subspecialized remote radiology interpretation services across body imaging, breast imaging, musculoskeletal, neuroradiology, pediatric radiology, and emergency radiology. Supports Lumexa's 190+ imaging centers and external clients with a network of 1,000+ subspecialized radiologists, delivering accelerated turnaround times and reliable capacity amid national radiologist shortages.

Quantifiable outcome

  • Approximately 60% cost savings compared to hospital outpatient departments for equivalent imaging services (based on 2019 UnitedHealth Group claims analysis)
  • +6 more outcomes

Companies that use Lumexa Imaging

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Lumexa Imaging technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature7 records

Lumexa Imaging partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered flagship and core.

  • Hospital for Special Surgery (HSS)flagshipStrategic or Co-development Partner · 2 June 2026Lumexa Imaging formed a strategic joint venture with Hospital for Special Surgery (HSS), world leader in musculoskeletal health ranked No. 1 in orthopedics by U.S. News & World Report for 16 consecutive years. The collaboration represents Lumexa's 9th joint venture and aims to expand access to advanced outpatient imaging services across the New York City metro area. The joint venture leverages HSS's subspecialized radiology expertise and supports Lumexa's growth in one of the nation's largest healthcare markets.
  • UPMCcoreStrategic or Co-development Partner · 13 May 2026New joint venture partnership with UPMC (University of Pittsburgh Medical Center). Wexford, Pennsylvania site represents the first contribution from the new joint venture. North Pittsburgh Imaging Specialists in Pine Township was acquired and rebranded as UPMC | Touchstone Medical Imaging as part of this partnership. UPMC is a leading health system operating in Pennsylvania and surrounding states.
  • Advocate HealthcoreStrategic or Co-development Partner · 13 May 2026Joint venture partnership with Advocate Health, one of the largest health systems operating in seven states. A center in Concord, North Carolina was acquired as part of this joint venture partnership. Advocate Health represents an existing JV partner relationship supporting Lumexa's multi-channel growth strategy.
  • Radiology Practice PartnerscoreStrategic or Co-development Partner · 11 December 2025Lumexa Imaging partners with leading subspecialized private practice radiology groups across its 190+ center footprint. Each practice maintains local Clinical Governance Board (CGB) for patient care decisions and local hiring, scheduling, and salary decisions. Partners include Charlotte Radiology, Carolinas Imaging, Gateway Radiology, Rad Ltd, SJRA, Windsong Radiology, and others. Together the network comprises over 1,000 radiologists.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Lumexa Imaging competitors and assessment

Company assessment

Direct peers

  • RadNet: RadNet is the largest U.S. outpatient diagnostic imaging network with ~400 centers across multiple states. It is the most direct competitor to Lumexa in freestanding MRI/CT/PET/mammography services and the #1 player in the same outpatient imaging category where Lumexa is #2.
  • SimonMed Imaging: SimonMed is one of the largest privately held outpatient diagnostic imaging providers in the U.S., offering MRI, CT, PET/CT, mammography, and other modalities. It competes head-to-head with Lumexa in many of the same MSAs and serves a similar patient and referring-physician base.
  • RAYUS Radiology: RAYUS Radiology (formerly Center for Diagnostic Imaging) is a national outpatient imaging network operating freestanding centers with MRI, CT, and other modalities. It is a directly comparable outpatient imaging peer to Lumexa, sharing the same freestanding-center, multi-modality service model.
  • Akumin: Akumin operates a national network of freestanding outpatient imaging centers offering MRI, CT, PET/CT, and other diagnostic services. Despite recent financial restructuring, it remains a directly comparable outpatient diagnostic imaging peer to Lumexa.
  • Radiology Partners: Radiology Partners is the largest radiology practice in the U.S., serving hospitals and outpatient imaging centers through teleradiology and on-site radiologist staffing. It is directly comparable to Lumexa's Connexia teleradiology and subspecialized radiologist network, though it does not own imaging centers at scale.

Broad incumbents

  • Envision Physician Services: Envision provides outsourced clinical staffing, including radiology, to hospitals and health systems across the U.S. It is a broader healthcare-services incumbent that overlaps with Lumexa's outsourced radiology and teleradiology services but across a much wider clinical portfolio.
  • HCA Healthcare: HCA is the largest U.S. for-profit hospital system and operates a broad network of hospital outpatient imaging departments. It is a broad incumbent whose HOPD imaging services compete with Lumexa's freestanding centers and whose joint-venture-friendly operating model is structurally relevant to Lumexa's JV strategy.
  • Tenet Healthcare / United Surgical Partners International: Tenet, through USPI, is the largest operator of ambulatory surgery centers and a major outpatient healthcare services platform. It is a broad incumbent with a similar JV-driven growth playbook, providing a comparable public-market benchmark for Lumexa's growth and margin trajectory.

Emerging players

  • SCA Health (Surgical Care Affiliates): SCA Health operates a national network of ambulatory surgery centers and partnered with Optum. While focused on outpatient surgery rather than imaging, SCA uses a similar health-system JV and capital-efficient expansion model that informed Lumexa's CGO Kyle Lynch (formerly SVP at SCA Health).

Others

  • Innovative Health (and other imaging AI vendors): Independent imaging AI and analytics vendors serve the same radiology customer base as Lumexa's Connexia teleradiology and AI tools. They are adjacent ecosystem participants whose competitive positioning directly affects Lumexa's technology differentiation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Lumexa Imaging social profiles

Digital presence

Lumexa Imaging financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lumexa Imaging leadership team

Management profile

Number of profiles

Profiles21 records

Lumexa Imaging subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Lumexa Imaging funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lumexa Imaging M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lumexa Imaging

What does Lumexa Imaging do?

Lumexa Imaging operates a national network of 190+ freestanding outpatient diagnostic imaging centers across 13 U.S. states, providing MRI, CT, PET/CT, mammography, and interventional radiology services to patients referred by physicians. The company complements its imaging centers with the proprietary Connexia teleradiology platform, delivering subspecialized remote radiology interpretations across body, breast, musculoskeletal, neuroradiology, pediatric, and emergency radiology supported by 1,000+ radiologists. AI-powered tools including Scanslated, Rad AI, FastScan, and breast arterial calcification detection enhance clinical quality, patient engagement, and operational efficiency across the network.

Is Lumexa Imaging a public or private company?

Lumexa Imaging is a public company. It is classified as public and is currently operating.

When was Lumexa Imaging founded?

Lumexa Imaging was founded in 2018. It employs 501 to 1,000 people.

Where is Lumexa Imaging based?

Lumexa Imaging is headquartered in Raleigh, United States, in the North America region.

How does Lumexa Imaging make money?

Three revenue lines are on record. Outpatient Imaging Services are the primary driver. The others are joint Venture Partnerships with Health Systems and teleradiology Services (Connexia).

Who are Lumexa Imaging's main competitors?

Direct peers on record are RadNet, SimonMed Imaging, RAYUS Radiology, Akumin and Radiology Partners. Broad incumbents are Envision Physician Services, HCA Healthcare and Tenet Healthcare / United Surgical Partners International. SCA Health (Surgical Care Affiliates) is listed as an emerging player. Innovative Health (and other imaging AI vendors) is listed as an others.

Does Lumexa Imaging have an API?

No public API is recorded for Lumexa Imaging.

What industry is Lumexa Imaging in?

Lumexa Imaging's product category is Outpatient Diagnostic Imaging Services. Its primary akta.pro industry code is HLAFAKAA, Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound), with a secondary code of HLACALAK, Teleradiology Platforms & Reading Workflow. Its NAICS code is 621512 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TradingViewBarclays maintains Lumexa Imaging Hldgs at Overweight, raises price target to $17 from $13Barclays maintained Lumexa Imaging Hldgs at Overweight and raised its price target to $17 from $13, a 30.8% increase. The target implies a 14.9% upside from the Nov 16 close of $14.79.Simply Wall StLumexa Imaging Holdings (LMRI) Stock Looks Fully Valued Despite Reiterated 2026 GuidanceLumexa Imaging Holdings shares rose 40.8% over the past month, trading at a P/S of about 1.4x, above the healthcare sector's 1.3x and peers' 1.2x. Management reiterated 2026 revenue guidance, but the valuation appears overvalued relative to the Fair Ratio. Analyst narratives suggest a 34% undervaluation or 15% overvaluation depending on future execution.Business & FinancialLumexa Imaging Expands Partnership With Advocate Health Through New Illinois Joint VentureLumexa Imaging announced a new joint venture with Advocate Health to expand outpatient imaging services in Illinois. The deal builds on an existing partnership, and Lumexa now has 10 joint ventures with 9 health systems. The company aims to bring its clinical and operational expertise to the new market.TradingViewLumexa Imaging Holdings, Inc. Stock 12‑Month Price Target Raised to $17.89, Implies 29% UpsideAnalysts' average price target for Lumexa Imaging Holdings rose to $17.89 from $17.67, implying about 29% upside from the Nov. 10 close. The consensus remains a Buy across 10 analysts, with forecasts ranging from $13 to $23 per share.Seeking AlphaLumexa Imaging Holdings, Inc. (LMRI) Q3 2026 Earnings Call TranscriptLumexa Imaging Holdings held its Q3 2026 earnings call on November 10, 2026, with CEO Caitlin Zulla and CFO Tony Martin leading. The call included forward-looking statements about 2026 guidance and operating performance, with no specific financial figures disclosed in the transcript.ChartmillLumexa Imaging Holdings (NASDAQ:LMRI) Q3 Revenue In Line, Adjusted EPS Beats and Guidance RaisedLumexa Imaging Holdings reported Q3 2026 revenue of $272.0 million, slightly below consensus, while adjusted EPS of $0.26 beat estimates by about 40%. The company raised its full-year adjusted EPS guidance to $0.86–$0.90, driven by a lower assumed tax rate, and reiterated revenue guidance of $1.045–$1.097 billion.Seeking AlphaLumexa Imaging Holdings, Inc. Non-GAAP EPS of $0.26 beats by $0.08, revenue of $272M beats by $2.11M (NASDAQ:LMRI)Lumexa Imaging Holdings reported Q3 non-GAAP EPS of $0.26, beating estimates by $0.08, and revenue of $272 million, up 5.1% year-over-year, beating by $2.11 million. The company's stock closed at $13.92, down 0.36%.Stock TitanLumexa Imaging Q3 Earnings: Revenue Rises 5% to $272MLumexa Imaging reported Q3 2026 revenue of $272 million, up 5% year over year, and net income of $7.2 million, a return to quarterly profit. The company raised its full-year 2026 Adjusted EPS guidance to $0.86–$0.90 per share and reiterated revenue guidance of $1.045–$1.097 billion.MarketBeatLumexa Imaging Holdings, Inc. $LMRI Shares Newly Bought by Brooklands Fund Management LtdBrooklands Fund Management Ltd bought a new stake in Lumexa Imaging Holdings, purchasing 2,105,059 shares worth about $21.6 million in Q3. The stock now represents 3.2% of the firm's portfolio, and analysts have a consensus Buy rating with a $16.40 price target.Business & FinancialLumexa Imaging Announces Third Quarter 2026 Earnings Conference Call DateLumexa Imaging announced the date for its third-quarter 2026 earnings conference call, with the live audio webcast available on its investor relations website. A replay will be available for approximately one year. The company reported conducting about 4 million outpatient procedures system-wide in 2025.